A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation

Cited by (1,005)

Items 501–600 of 1,005

1. Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation
   Jonathan Nyong, Guy Amit, Alma J Adler, Onikepe Owolabi, Pablo Perel, David Prieto‐Merino, Pier David Lambiase, Juan Pablo Casas, Carlos Arturo Morillo · 2016 · Cochrane Database of Systematic Reviews
2. Clinical factors that influence response to treatment strategies in atrial fibrillation: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study
   The AFFIRM Investigators · 2005 · American Heart Journal
3. Changes in left atrial size in patients with persistent atrial fibrillation: a prospective echocardiographic study with a 5-year follow-up period
   Beata Wożakowska−Kapłon · 2004 · International Journal of Cardiology
4. Atrial Fibrillation Ablation: Reaching the Mainstream
   John D. Fisher, Michael A. Spinelli, Disha Mookherjee, ANDREW K. KRUMERMAN, Eugen Palma · 2006 · Pacing and Clinical Electrophysiology
5. Dronedarone for Atrial Fibrillation — An Odyssey
   PETER J. ZIMETBAUM · 2009 · New England Journal of Medicine
6. Impact of the type of centre on management of AF patients: Surprising evidence for differences in antithrombotic therapy decisions
   Andrea Gerth, Tobias Limbourg, Thorsten Lewalter, Andreas Goette, Karl Wegscheider, András Treszl, Thomas Meinertz, Michael Oeff, Ursula Ravens, GÜNTER E. BREITHARDT et al. · 2011 · Thrombosis and Haemostasis
7. Rate versus rhythm control in atrial fibrillation and clinical outcomes: Updated systematic review and meta-analysis of randomized controlled trials
   Daniel Caldeira, Cláudio David, Cristina Sampaio · 2012 · Archives of cardiovascular diseases
8. Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation ? results from the RAte Control versus Electrical cardioversion (RACE) study
   VE Hagens, Karin Marianne Vermeulen, Elisabeth M. TenVergert, D VANVELDHUISEN, Hans A. Bosker, Otto Kamp B, Jan Herre Kingma, Jan G.P. Tijssen, Harry J.G.M. Crijns, IC VanGelder · 2004 · European Heart Journal
9. Atrial fibrillation in chronic non-cardiac disease: Where do we stand?
   Mitja Lainščak, Nikolaos Dagres, Gerasimos S Filippatos, Stefan D. Anker, Dimitrios Th. Kremastinos · 2008 · International Journal of Cardiology
10. Digoxin in patients with permanent atrial fibrillation: Data from the RACE II study
    Bart A. Mulder, Dirk Jan van Veldhuisen, Harry J.G.M. Crijns, Jan G.P. Tijssen, Hans L. Hillege, Marco Alings, Michiel Rienstra, Maarten P. van den Berg, Isabelle C. Van Gelder · 2014 · Heart Rhythm
11. Management of Atrial Fibrillation in Critically Ill Patients
    Mattia Arrigo, Dominique Béttex, Alain Rudiger · 2014 · Critical Care Research and Practice
12. Recent mortality of Japanese patients with atrial fibrillation in an urban city of Tokyo
    Shinya S. Suzuki, Takeshi Yamashita, Takayuki Otsuka, Koichi Sagara, Tokuhisa Uejima, Yuji Oikawa, Junji Yajima, Akira Koike, Kazuyuki Nagashima, Hajime Kirigaya et al. · 2011 · Journal of Cardiology
13. New Insights into Long‐Term Follow‐Up of Atrial Fibrillation Ablation: Full Disclosure by an Implantable Pacemaker Device
    Martin Martinek, Josef Aichinger, Hans‐Joachim Nesser, Paul Ziegler, Helmut Pürerfellner · 2007 · Journal of Cardiovascular Electrophysiology
14. Radiofrequency catheter ablation of atrial fibrillation in older patients: outcomes and complications
    Fred M Kusumoto, Karin A. Prussak, Melissa Wiesinger, Tammy Pullen, Cynthia Lynady · 2009 · Journal of Interventional Cardiac Electrophysiology
15. The Incidence, Pattern, and Prognostic Value of Left Ventricular Myocardial Scar by Late Gadolinium Enhancement in Patients With Atrial Fibrillation
    Tomas G. Neilan, Ravi V. Shah, Siddique A. Abbasi, Hoshang Farhad, John D. Groarke, John A. Dodson, Otávio R. Coelho‐Filho, Ciaran J. McMullan, Bobak Heydari, Gregory F. Michaud et al. · 2013 · Journal of the American College of Cardiology
16. Continuous vs Episodic Prophylactic Treatment With Amiodarone for the Prevention of Atrial Fibrillation
    Sheba Ahmed, Michiel Rienstra, Harry J.G.M. Crijns, Thera P. Links, Ans C.P. Wiesfeld, Hans L. Hillege, Hans A. Bosker, Dirk J. A. Lok, Dirk Jan van Veldhuisen, Isabelle C. Van Gelder et al. · 2008 · JAMA
17. The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis
    Naqash J Sethi, Joshua Buron Feinberg, Emil Eik Nielsen, Sanam Safi, Christian Nyfeldt Gluud, Janus Christian Jakobsen · 2017 · PLoS ONE
18. Dose-Response Effects of Bepridil in Patients With Persistent Atrial Fibrillation Monitored With Transtelephonic Electrocardiograms A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study (J-BAF Study)
    Takeshi Yamashita, Satoshi Ogawa, Toshiaki Sato, Yoshifusa Aizawa, Hirotsugu Atarashi, Akira Fujiki, Hiroshi Inoue, Makoto Ito, Takao Katoh, Youichi Kobayashi et al. · 2009 · Circulation Journal
19. Enfermedad cardiovascular en el anciano
    Charles F. Jackson, NANETTE KASS WENGER · 2011 · Revista Española de Cardiología
20. Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score
    Thomas Kleemann, T. Becker, M. Strauss, Steffen Schneider, K. Seidl · 2008 · European Journal of Echocardiography
21. Safety considerations in the pharmacological management of atrial fibrillation
    A. John Camm · 2008 · International Journal of Cardiology
22. Impact of atrial fibrillation catheter ablation on mortality, stroke, and heart failure hospitalizations: A meta‐analysis
    Andrea Saglietto, Roberto De Ponti, Luigi Di Biase, Mario Matta, Fiorenzo Gaïta, Jorge E. Romero, Gaetano Maria De Ferrari, Matteo Anselmino · 2020 · Journal of Cardiovascular Electrophysiology
23. Health-Related Quality of Life in Patients With Atrial Fibrillation Treated With Rhythm Control Versus Rate Control
    Andrew C.T. Ha, GÜNTER E. BREITHARDT, A. John Camm, Harry J.G.M. Crijns, Garrett M. Fitzmaurice, Peter Russell Kowey, Jean‐Yves Le Heuzey, Lisa Naditch‐Brûlé, Eric N. Prystowsky, Peter J. Schwartz et al. · 2014 · Circulation Cardiovascular Quality and Outcomes
24. Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher
    Yenn‐Jiang Lin, Tze‐Fan Chao, Hsuan-Ming Tsao, Shih‐Lin Chang, Li‐Wei Lo, Chern‐En Chiang, Yu‐Feng Hu, Pai‐Feng Hsu, Shao‐Yuan Chuang, Cheng-Hung Li et al. · 2012 · EP Europace
25. Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. The BEST AF Trial
    Benedict M. Glover, Simon J Walsh, Conor J. McCann, M J Moore, Gunasekar Manoharan, Gavin W.N. Dalzell, Andrew S. McAllister, Brian M. McClements, DAVID J. MCENEANEY, Tom G. Trouton et al. · 2007 · Heart
26. Outcomes for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter Treated in Canadian Hospitals
    Ian Gilmour Stiell, Catherine M. Clement, Brian Hunter Rowe, Robert James Brison, D. George Wyse, David H. Birnie, Paul Dorian, Eddy Lang, Jeffrey Joseph Perry, Bjug Borgundvaag et al. · 2017 · Annals of Emergency Medicine
27. Amiodarone and Optic Neuropathy: The Heart of the Matter
    Marjorie A Murphy, John F. Murphy · 2005 · Journal of Neuro-Ophthalmology
28. Risk of proarrhythmic events in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study
    Elizabeth S. Kaufman, Paul A. Zimmermann, Ted Wang, George W. Dennish, Patrick Barrell, Mary L. Chandler, H.Leon Greene · 2004 · Journal of the American College of Cardiology
29. Progress in Nonpharmacologic Therapy of Atrial Fibrillation
    Douglas L. Packer, Samuel J. Asirvatham, Thomas M. Munger · 2003 · Journal of Cardiovascular Electrophysiology
30. Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus
    Young, Lawrence H., Viscoli, Catherine M., Curtis, Jeptha P., Inzucchi, Silvio E., Schwartz, Gregory G., Lovejoy, Anne M., Furie, Karen L., Gorman, Mark J., Conwit, Robin, Abbott, J. Dawn et al. · 2017 · Circulation
31. Relation of Digoxin Use in Atrial Fibrillation and the Risk of All-Cause Mortality in Patients ≥65 Years of Age With Versus Without Heart Failure
    Mitesh Shah, Meytal Avgil Tsadok, Cynthia Anne Jackevicius, Vidal Essebag, Hassan Behlouli, Louise Pilote · 2014 · The American Journal of Cardiology
32. Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it
    Stanley Nattel, Philip T. Sager, Jörg Hüser, Jordi Heijman, Dobromir Dobrev · 2021 · Cardiovascular Research
33. Analysis of Current Management of Atrial Fibrillation in the Acute Setting: GEFAUR-1 Study
    Carmen del Arco, Alfonso Martı́n, Pedro Laguna, Pedro Gargantilla · 2005 · Annals of Emergency Medicine
34. The impact of surgical ablation in patients with low ejection fraction, heart failure, and atrial fibrillation
    Niv Ad, Linda L Henry, Sharon Hunt · 2010 · European Journal of Cardio-Thoracic Surgery
35. Heart rate is associated with progression of atrial fibrillation, independent of rhythm
    Fredrik Holmqvist, Sunghee Kim, Benjamin Adam Steinberg, James A. Reiffel, Kenneth W. Mahaffey, Bernard John Gersh, Gregg C. Fonarow, Gerald V. Naccarelli, Paul Chang, James V. Freeman et al. · 2015 · Heart
36. Exercise capacity in atrial fibrillation: A substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T)
    J. Edwin Atwood, JONATHAN N. MYERS, X. Charlene Tang, Domenic J. Reda, Steven N Singh, Bramah N. Singh · 2007 · American Heart Journal
37. Atrial fibrillation in heart failure with preserved ejection fraction: Insights into mechanisms and therapeutics
    Ravi B. Patel, Muthiah Vaduganathan, Sanjiv Jayendra Shah, Javed Butler · 2016 · Pharmacology & Therapeutics
38. Vagal atrial fibrillation: What is it and should we treat it?
    Carpenter, Alexander, Frontera, Antonio, Bond, Richard, Duncan, Edward, Thomas, Glyn · 2015 · International Journal of Cardiology
39. Arrhythmia-induced cardiomyopathies: the riddle of the chicken and the egg still unanswered?
    EMMANUEL N. SIMANTIRAKIS, Emmanuel P. Koutalas, Panos E. Vardas · 2011 · EP Europace
40. Raised Plasma Aldosterone and Natriuretic Peptides in Atrial Fibrillation
    Ulrik Dixen, Lasse Steen Ravn, Christian Soeby-Rasmussen, Anders Wallin Paulsen, Jan Parner, Erik L. Frandsen, Gorm Boje Jensen · 2006 · Cardiology
41. Thirty‐day Outcomes of Emergency Department Patients Undergoing Electrical Cardioversion for Atrial Fibrillation or Flutter
    Frank Xavier Scheuermeyer, Eric Grafstein, Rob Stenstrom, Grant D Innes, Iraj M. Poureslami, Maziar Sighary · 2010 · Academic Emergency Medicine
42. The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm
    Isabelle C. Van Gelder, Martin E.W. Hemels · 2006 · EP Europace
43. Antiarrhythmic, serotonin antagonist and antianxiety activities of novel substituted thiophene derivatives synthesized from 2-amino-4,5,6,7-tetrahydro-N-phenylbenzo[b]thiophene-3-carboxamide
    Abd El‐Galil E. Amr, Mohamed H. Sherif, Mohamed G. Assy, Mohamed Abdulrahman Al-Omar, Islam Ragab · 2010 · European Journal of Medicinal Chemistry
44. Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT‐AF)
    Benjamin Adam Steinberg, Sunghee Kim, Laine Elliott Thomas, Gregg C. Fonarow, Bernard John Gersh, Fredrik Holmqvist, Elaine M. Hylek, Peter Russell Kowey, Kenneth W. Mahaffey, Gerald V. Naccarelli et al. · 2015 · Journal of the American Heart Association
45. Accumulation of Risk Factors Increases Risk of Thromboembolic Events in Patients With Nonvalvular Atrial Fibrillation
    Hiroshi Inoue, Takashi Nozawa, Tadakazu Hirai, Atsushi Iwasa, Ken Okumura, Jong‐Dae Lee, Akihiko Shimizu, Motonobu Hayano, Katsusuke Yano · 2006 · Circulation Journal
46. European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care
    Richard F. Hobbs, Clare J Taylor, Geert Jan Geersing, Frans Hendrik Rutten, Judith Rixt Brouwer, on behalf of the European Primary Care Cardiovascular Society (EPCCS) SPAF working group · 2015 · European Journal of Preventive Cardiology
47. Guidelines for Treatment of Acute Heart Failure (JCS 2011) : Digest Version
    Tohru Izumi, Atsushi Hirayama, Mitsuaki Isobe, Hiroshi Ito, Masafumi Kitakaze, Momomura Shin'ichi, Yoshiki Sawa, Yoshihiko Seino, Hiroyuki Tsutsui, Kenji Yamazaki et al. · 2013 · Japanese Circulation Journal-english Edition
48. Biatrial and Three‐Dimensional Mapping of Spontaneous Atrial Arrhythmias in Patients with Refractory Atrial Fibrillation
    Sanjeev V. Saksena, Nicholas D. Skadsberg, Hygriv B. Rao, Artur Filipecki · 2005 · Journal of Cardiovascular Electrophysiology
49. New developments in atrial antiarrhythmic drug therapy
    Alexander Burashnikov, Charles N Antzelevitch · 2010 · Nature Reviews Cardiology
50. Warfarin in haemodialysis patients with atrial fibrillation: what benefit?
    Felix Yang, Denise E. Chou, Paul Schweitzer, Sam Hanon · 2010 · EP Europace
51. Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation
    Christian Knackstedt, Felix Gramley, Thomas Schimpf, Karl Mischke, Markus Zarse, Jurgita Plisienė, Michael Schmid, Johann Lorenzen, Dirk Frechen, Philip Neef et al. · 2008 · Cardiovascular Pathology
52. Prognostic impact of restored sinus rhythm in patients with sepsis and new-onset atrial fibrillation
    Wen Cheng Liu, Wen Yu Lin, Chin Sheng Lin, Han Huang, Tzu Chiao Lin, Shu Meng Cheng, Shih Ping Yang, Jung Chung Lin, Wei Shiang Lin · 2016 · Critical Care
53. Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials
    Ahmed AlTurki, Riccardo Proietti, Ahmed Dawas, Hasan Alturki, Thao Thanh Huynh, Vidal Essebag · 2019 · BMC Cardiovascular Disorders
54. Atrial fibrillation
    M. Thomas, Liqun Wu, K. Win · 2014 · Journal of Biomedical Research
55. Atrial fibrillation: an emerging epidemic?
    Joan S. Steinberg · 2004 · Heart
56. Antiarrhythmic drugs for the maintenance of sinus rhythm: Risks and benefits
    A. John Camm · 2011 · International Journal of Cardiology
57. Effect of Renal Sympathetic Denervation on Atrial Substrate Remodeling in Ambulatory Canines with Prolonged Atrial Pacing
    Xule Wang, Qingyan Zhao, He Huang, Yanhong Tang, Jinping Xiao, Zixuan Dai, Shengbo Yu, Congxin Huang · 2013 · PLoS ONE
58. Atrial fibrillation in dogs with and without structural or functional cardiac disease: A retrospective study of 109 cases
    Pierre Menaut, Marie C. Bélanger, Guy Beauchamp, Nicole M. Ponzio, N. Sydney Möise · 2005 · Journal of Veterinary Cardiology
59. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias
    Eduard Shantsila, Timothy Watson, Gregory Y.H. Lip · 2007 · EP Europace
60. Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world
    Alexandre Meiltz, Marc Zimmermann, Philip M. Urban, A Bloch · 2008 · EP Europace
61. Persistent atrial fibrillation vs paroxysmal atrial fibrillation: differences in management
    Andrei Dumitru Margulescu, Lluı́s Mont · 2017 · Expert Review of Cardiovascular Therapy
62. Rationale and current perspective for early rhythm control therapy in atrial fibrillation
    Isabelle C. Van Gelder, Laurent Haegeli, Axel Brandes, Hein Heidbüchel, Etienne Aliot, J. Kautzner, Łukasz Jan Szumowski, Lluı́s Mont, John Mark Morgan, Stephan Willems et al. · 2011 · EP Europace
63. Impact of Transforming Growth Factor-β1 on Atrioventricular Node Conduction Modification by Injected Autologous Fibroblasts in the Canine Heart
    Thomas Jared Bunch, Srijoy Mahapatra, G. Keith Bruce, Susan B. Johnson, Dylan V. Miller, Benjamin Davies Horne, Xiao-Li Wang, Hon-Chi Lee, Noel M. Caplice, Douglas L. Packer · 2006 · Circulation
64. Management of postoperative atrial fibrillation
    Takeshi Omae, Yuichi Kanmura · 2012 · Journal of Anesthesia
65. The CURE-AF trial: A prospective, multicenter trial of irrigated radiofrequency ablation for the treatment of persistent atrial fibrillation during concomitant cardiac surgery
    Ralph J. Damiano, Vinay Badhwar, Michael A. Acker, Ramesh S. Veeragandham, David C. Kress, Jason O. Robertson, Thoralf M. Sundt · 2013 · Heart Rhythm
66. Atrial fibrillation in haemodialysis patients: Do the guidelines for anticoagulation apply?
    Andrew C. Y. To, Maha Yehia, John F Collins · 2007 · Nephrology
67. Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project
    Joanne L. Lord, Sarah Willis, Julie Eatock, Paul Tappenden, Marta Trapero‐Bertran, Alec H. Miners, Catriona Crossan, Maggie J Westby, Anastasia Anagnostou, Simon J. E. Taylor et al. · 2013 · Health Technology Assessment
68. Systematic screening for the detection of atrial fibrillation
    Patrick S. Moran, Conor Teljeur, Máirín Ryan, Susan M. Smith · 2016 · Cochrane Database of Systematic Reviews
69. Subcutaneous Implantable Cardioverter Defibrillator
    Christopher P. Rowley, Michael Robert Gold · 2012 · Circulation Arrhythmia and Electrophysiology
70. Effectiveness of systematic screening for the detection of atrial fibrillation
    Patrick S. Moran, Martin J Flattery, Conor Teljeur, Máirín Ryan, Susan M. Smith · 2013 · Cochrane Database of Systematic Reviews
71. Atrial Fibrillation Associated with Heart Failure, Stroke and Mortality.
    Stefano Bordignon, Maria Chiara Corti, Claudio Bilato · 2012 · Europe PMC (PubMed Central)
72. Holter monitoring in the diagnosis of stroke mechanism
    S Shafqat, Peter J. Kelly, Karen L. Furie · 2004 · Internal Medicine Journal
73. Hypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications
    Kai‐Hang Yiu, Hung‐Fat Tse · 2008 · Journal of Human Hypertension
74. Heart Rate and Heart Failure - Not a Simple Relationship -
    Gerd Heusch · 2010 · Circulation Journal
75. Mean platelet volume: a potential biomarker of the risk and prognosis of heart disease
    Dong-Hyun Choi, Seong‐Ho Kang, Heesang Song · 2016 · The Korean Journal of Internal Medicine
76. Relationship between pattern of occurrence of atrial fibrillation and surface electrocardiographic fibrillatory wave characteristics
    Xi Qin, Alan Varteres Sahakian, Thomas G. Frohlich, Jason Ng, Steven Swiryn · 2004 · Heart Rhythm
77. Impact of Atrial Fibrillation on Mortality and Readmission in oLder Adults Hospitalized with Heart Failure
    Ali Ahmed, Phillip L. Thornton, Gilbert J. Perry, Richard M. Allman, James F. DeLong · 2004 · European Journal of Heart Failure
78. Atrial Fibrillation
    A. John Camm, Irina Savelieva, Siew Yen Ho, Bruce D. Lindsay, Stanley Nattel, Kaori Shinagawa · 2009 · Elsevier eBooks
79. Risk of stroke after catheter ablation versus cardioversion for atrial fibrillation: A propensity-matched study of 24,244 patients
    Peter A. Noseworthy, Suraj Kapa, Abhishek J. Deshmukh, Malini Madhavan, Holly Van Houten, Lindsey R. Haas, Siva K. Mulpuru, Christopher John McLeod, Samuel J. Asirvatham, Paul A. Friedman et al. · 2015 · Heart Rhythm
80. Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease
    Xiaoyan Wu, Songnan Li, Songnan Wen, Jungang Nie, Wenning Deng, Rong Bai, Nian Liu, Ribo Tang, Ting Zhang, Xin Du et al. · 2015 · EP Europace
81. Electrocardiography and Outcome in Patients with Diabetes Mellitus on Maintenance Hemodialysis
    Vera Krane, Fritz Heinrich, Malte Meesmann, Manfred Olschewski, Ju[Combining Diaeresis]rgen Lilienthal, Christiane Angermann, Stefan Störk, Johann K Bauersachs, Christoph Wanner, Stefan Frantz · 2009 · Clinical Journal of the American Society of Nephrology
82. Nine-Year Trend of Anticoagulation Use, Thromboembolic Events, and Major Bleeding in Patients With Non-Valvular Atrial Fibrillation – Shinken Database Analysis –
    Shinya S. Suzuki, Takayuki Otsuka, Koichi Sagara, Hiroaki Semba, Hiroto Kano, Shunsuke Matsuno, Hideaki Takai, Yuko Kato, Tokuhisa Uejima, Yuji Oikawa et al. · 2016 · Circulation Journal
83. How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?
    Rajiv Sankaranarayanan, Graeme J. Kirkwood, Rajaverma Visweswariah, David J. Fox · 2015 · Current Cardiology Reviews
84. The Impact of Suppressing the Renin‐Angiotensin System on Atrial Fibrillation
    James S. Kalus, Craig Ian Coleman, Charles Michael White · 2006 · The Journal of Clinical Pharmacology
85. Drug therapy for atrial fibrillation: where do we go from here?
    Richard L. Page, Dan M. Roden · 2005 · Nature Reviews Drug Discovery
86. Investigation of the Optimal Treatment Strategy for Atrial Fibrillation in Japan-The J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Study Design-
    Takeshi Yamashita, Satoshi Ogawa, Yoshifusa Aizawa, Hirotsugu Atarashi, Hiroshi Inoue, Tohru Ohe, Ken Okumura, Takao Kato, Shiro Kamakura, Koichiro Kumagai et al. · 2003 · Circulation Journal
87. Successful catheter ablation of persistent atrial fibrillation is associated with improvement in functional tricuspid regurgitation and right heart reverse remodeling
    Kiho Itakura, Takayuki Hidaka, Yukiko Nakano, Hiroto Utsunomiya, Mirai Kinoshita, Hitoshi Susawa, Y Harada, Kanako Izumi, Yasuki Kihara · 2020 · Heart and Vessels
88. Atrial Fibrillation (AFIB) in the ICU: Incidence, Risk Factors, and Outcomes: The International AFIB-ICU Cohort Study*
    Mik Wetterslev, Morten Hylander Møller, Anders Granholm, Christian Hassager, Nicolai Haase, Theis Lange, Sheila Nainan Myatra, Johanna Hästbacka, Yaseen M. Arabi, Jiawei Shen et al. · 2023 · Critical Care Medicine
89. The Use of a Modified Sphygmomanometer to Detect Atrial Fibrillation in Outpatients
    Joseph Wiesel, David J. Wiesel, Ranjit Suri, Frank C. Messineo · 2004 · Pacing and Clinical Electrophysiology
90. Cost Burden of Cardiovascular Hospitalization and Mortality in ATHENA‐Like Patients With Atrial Fibrillation/Atrial Flutter in the United States
    Gerald V. Naccarelli, Stephen S. Johnston, Jay Lin, Parag P. Patel, Kathy L. Schulman · 2010 · Clinical Cardiology
91. Obesity and Outcomes Among Patients With Established Atrial Fibrillation
    Afrooz Ardestani, Heather J. Hoffman, Howard A. Cooper · 2010 · The American Journal of Cardiology
92. Refining the In Vitro and In Vivo Critical Parameters for P-Glycoprotein, [I]/IC 50 and [I 2 ]/IC 50 , That Allow for the Exclusion of Drug Candidates from Clinical Digoxin Interaction Studies
    Jack Cook, Bo Feng, Katherine S. Fenner, Sarah Kempshall, Ray Liu, Charles J. Rotter, Dennis A. Smith, Matthew D. Troutman, Mohammed Ullah, Caroline A. Lee · 2009 · Molecular Pharmaceutics
93. Managing Emergency Department Patients with Recent-onset Atrial Fibrillation
    David R. Vinson, Ted Hoehn, David J. Graber, Terry M. Williams · 2010 · Journal of Emergency Medicine
94. Electrocardiology of atrial fibrillation
    Andreas Bollmann, Federico Lombardi · 2006 · IEEE Engineering in Medicine and Biology Magazine
95. Cause of Very Late Recurrence of Atrial Fibrillation or Flutter After Catheter Ablation for Atrial Fibrillation
    Yohei Sotomi, Koichi Inoue, Norihisa Ito, Ryusuke Kimura, Yuko Toyoshima, Masaharu Masuda, Atsushi Doi, Katsuomi Iwakura, Atsunori Okamura, Yasushi Koyama et al. · 2012 · The American Journal of Cardiology
96. Gender-Related Differences in Atrial Fibrillation**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
    Charles R. Kerr, Karin H. Humphries · 2005 · Journal of the American College of Cardiology
97. Incidence of Atrial Fibrillation in Relation to Changing Heart Rate Over Time in Hypertensive Patients
    Peter M. Okin, Kristian Wachtell, Sverre Erik Kjeldsen, Stevo Julius, Lars Hjalmar Lindholm, Björn Dahlöf, Darcy A. Hille, Markku S. Nieminen, Jonathan M. Edelman, Richard B. Devereux · 2008 · Circulation Arrhythmia and Electrophysiology
98. Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure
    Udo Bavendiek, Lukas Aguirre Dávila, Armin Koch, Johann K Bauersachs · 2016 · European Heart Journal
99. Emerging Antiarrhythmic Drugs for Atrial Fibrillation
    Arnela Saljic, Jordi Heijman, Dobromir Dobrev · 2022 · International Journal of Molecular Sciences
100. Atrial fibrillation progression and the importance of early treatment for improving clinical outcomes
     Melanie Gunawardene, Stephan Willems · 2021 · EP Europace